VALUTAZIONE DEGLI EVENTI AVVERSI IN CORSO DI CHEMIOTERAPIA

Baselga J, Albanell J, Systemic therapy emergencies. Seminars in Oncology. ,vol. 27, pp. 347- 361 ,(2000)

John P. Timoney, Mary M. Eagan, Nancy T. Sklarin, Establishing clinical guidelines for the management of acute hypersensitivity reactions secondary to the administration of chemotherapy/biologic therapy Journal of Nursing Care Quality. ,vol. 18, pp. 80- 86 ,(2003) , 10.1097/00001786-200301000-00011

David W Bates, David J Cullen, Nan Laird, Laura A Petersen, Stephen D Small, Deborah Servi, Glenn Laffel, Bobbie J Sweitzer, Brian F Shea, Robert Hallisey, Martha Vander Vliet, Roberta Nemeskal, Lucian L Leape, David Bates, Patricia Hojnowski-Diaz, Stephen Petrycki, Michael Cotugno, Heather Patterson, Mairead Hickey, Sharon Kleefield, Jeffrey Cooper, Ellen Kinneally, Harold J Demonaco, Margaret Dempsey Clapp, Theresa Gallivan, Jeanette Ives, Kathy Porter, B Taylor Thompson, J Richard Hackman, Amy Edmondson, Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention JAMA. ,vol. 274, pp. 29- 34 ,(1995) , 10.1001/JAMA.1995.03530010043033

I Ralph Edwards, Jeffrey K Aronson, Adverse drug reactions: definitions, diagnosis, and management. The Lancet. ,vol. 356, pp. 1255- 1259 ,(2000) , 10.1016/S0140-6736(00)02799-9

S.P. Dourakis, V.A. Sevastianos, A. Alexopoulou, M. Deutsch, N. Stavrianeas, Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy. Journal of Clinical Oncology. ,vol. 20, pp. 3030- 3032 ,(2002) , 10.1200/JCO.2002.20.13.3030